Targeted delivery of antigens and CpG oligonucleotides to intracellular TLR9 receptors

被引：0
|
作者：
Salem, Aliasger K. [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 239卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
105-BIOT
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Inflammatory Non-CpG Antisense Oligonucleotides Are Signaling Thought TLR9 in Human Burkitt Lymphoma B Bjab Cells
    Pollak, Adam J.
    Cauntay, Patrick
    Machemer, Todd
    Paz, Suzanne
    Damle, Sagar
    Henry, Scott P.
    Burel, Sebastien A.
    NUCLEIC ACID THERAPEUTICS, 2022, 32 (06) : 473 - 485
  • [22] Evaluation of new TLR9 agonists for immunotherapy: Enantiomeric oligonucleotides (EnanDIM®)
    Kapp, K.
    Schmidt, M.
    Wittig, B.
    Schroff, M.
    Kleuss, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S9 - S9
  • [23] Lipid Nanoparticle Delivery Alters the Adjuvanticity of the TLR9 Agonist CpG by Innate Immune Activation in Lymphoid Tissue
    Zhong, Zifu
    Chen, Yong
    Deswarte, Kim
    Lauwers, Heleen
    De Lombaerde, Emily
    Cui, Xiaole
    Van Herck, Simon
    Ye, Tingting
    Gontsarik, Mark
    Lienenklaus, Stefan
    Sanders, Niek N.
    Lambrecht, Bart N.
    De Koker, Stefaan
    De Geest, Bruno G.
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (32)
  • [24] Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides
    Martin-Armas, M
    Simon-Santamaria, J
    Pettersen, I
    Moens, U
    Smedsrod, B
    Sveinbjornsson, B
    JOURNAL OF HEPATOLOGY, 2006, 44 (05) : 939 - 946
  • [25] Targeted Liposomal Delivery of TLR9 Ligands Activates Spontaneous Antitumor Immunity in an Autochthonous Cancer Model
    Hamzah, Juliana
    Altin, Joseph G.
    Herringson, Thomas
    Parish, Christopher R.
    Haemmerling, Guenter J.
    O'Donoghue, Helen
    Ganss, Ruth
    JOURNAL OF IMMUNOLOGY, 2009, 183 (02): : 1091 - 1098
  • [26] Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation
    Jurk, Marion
    Vollmer, Jorg
    BIODRUGS, 2007, 21 (06) : 387 - 401
  • [27] TLR9免疫识别CpG DNA的机制与途径
    李宁
    国外医学(分子生物学分册), 2003, (05) : 291 - 294
  • [28] Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy
    Jin, Yizhen
    Zhuang, Yuxin
    Dong, Xiaowu
    Liu, Mei
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) : 841 - 851
  • [29] Differential signaling by CpG DNA in DCs and B cells: not just TLR9
    Verthelyi, D
    Zeuner, RA
    TRENDS IN IMMUNOLOGY, 2003, 24 (10) : 519 - 522
  • [30] The transmembrane domain directs TLR9 to intracellular compartments that contain TLR3
    Kajita, E
    Nishiya, T
    Miwa, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (02) : 578 - 584
12345